Ana I. Velázquez Mañana: Best Poster in Urothelial Cancers at ESMO24 by Amanda Nizam

Ana I. Velázquez Mañana shared a post on X:

“Congratulations Amanda Nizam, mentor Vadim Koshkin and UNITE investigators awarded.

Best Poster in Urothelial Cancers at ESMO24 with their work evaluating pre-treatment risk factors for EV-induced peripheral neuropathy.

Dr. Nizam is a star.”

Dimitra R. Bakaloudi shared a post by Ana I. Velázquez Mañana on X, adding:

“Congrats Amanda Nizam!! So well Deserved my friend!”

Source: Ana I. Velázquez Mañana/X and Dimitra R. Bakaloudi/X

More posts featuring Ana I. Velázquez Mañana on oncodaily.com
Best of ESMO24

Ana Velázquez Mañana is an Assistant Professor of Medicine in the UCSF Division of Hematology/Oncology at Zuckerberg San Francisco General and a thoracic oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center. She serves as Assistant Director of Diversity, Equity, Inclusion, and Accessibility for Trainees of the UCSF Helen Diller Family Comprehensive Cancer Center and co-chairs the UCSF Department of Medicine Fellowship Diversity Committee. Her research, advocacy, and education efforts are focused on promoting and advancing health equity and workforce diversity. 

Dr. Amanda Nizam is a genitourinary (GU) medical oncologist at Cleveland Clinic, specializing in treating bladder, kidney, and prostate cancers. She is involved in clinical research and has contributed to discussions on various advanced treatment strategies for urothelial carcinoma, including immunotherapy, targeted therapies, and novel drug combinations. 

Dimitra Rafailia Bakaloudi is a Postdoctoral Research Fellow in the Division of Hematology and Oncology at the University of Washington, specializing in genitourinary medical oncology. She also serves as an Associate Researcher at NutricLab. Her research focuses on hygiene, preventive medicine, and medical statistics.